All SEC Filings :: Navidea Biopharmaceuticals, Inc. (NAVB)

Filing Type:

Year:

Date	Form	Description	Pages
08/10/10	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-10.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2	62
08/09/10	EFFECT	Notice of Effectiveness	1
08/03/10	S-3	Registration statement for specified transactions by certain issuers Documents EX-4.1 EX-5.1 EX-23.2 EX-24.1	59
07/27/10	UPLOAD	SEC-generated letter	1
07/20/10	8-K	Current report filing Documents EX-99.1 EX-99.2	10
07/19/10	3	Initial statement of beneficial ownership of securities Documents EX-24	3
07/19/10	3	Initial statement of beneficial ownership of securities Documents EX-24	3
07/15/10	8-K	Current report filing Documents EX-99.1	4
07/07/10	D	Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.	7
07/02/10	CORRESP	A correspondence can be sent as a document with another submission type or can be sent as a separate submission.	7